Cite
Maimouni S, Lee MH, Sung YM, et al. Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival. Oncotarget. 2021;12(22):2305-2306doi: 10.18632/oncotarget.28093.
Maimouni, S., Lee, M. H., Sung, Y. M., Hall, M., Roy, A., Ouaari, C., Hwang, Y. S., Spivak, J., Glasgow, E., Swift, M., Patel, J., Cheema, A., Kumar, D., & Byers, S. (2021). Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival. Oncotarget, 12(22), 2305-2306. https://doi.org/10.18632/oncotarget.28093
Maimouni, Sara, et al. "Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival." Oncotarget vol. 12,22 (2021): 2305-2306. doi: https://doi.org/10.18632/oncotarget.28093
Maimouni S, Lee MH, Sung YM, Hall M, Roy A, Ouaari C, Hwang YS, Spivak J, Glasgow E, Swift M, Patel J, Cheema A, Kumar D, Byers S. Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival. Oncotarget. 2021 Oct 26;12(22):2305-2306. doi: 10.18632/oncotarget.28093. eCollection 2021 Oct 26. PMID: 34733422; PMCID: PMC8555687.
Copy
Download .nbib